K5t7S

318. National Institute for Clinical Excellence (NICE). Intervencional procedures programme.
IPG330 Vagus nerve stimulation for treatment-resistant depression. London: NICE; 2009.
Disponible en: http://www.nice.org.uk/guidance/IPG330.
319. Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA, et al. Serial vagus nerve
stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology :
official publication of the American College of Neuropsychopharmacology. 2007;32(8):1649-
60.
320. Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve
stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol
Psychiatry. 2008;64(6):455-60.
321. Sperling W, Reulbach U, Kornhuber J. Clinical benefits and cost effectiveness of vagus nerve
stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry.
2009;42(3):85-8.
322. Franzini A, Messina G, Marras C, Savino M, Miniati M, Bugiani O, et al. Hamilton rating
scale for depression-21 modifications in patients with vagal nerve stimulation for treatment of
treatment-resistant depression: series report. Neuromodulation. 2008;11(4):267-71.
323. Sackeim HA, Brannan SK, Rush AJ, George MS, Marangell LB, Allen J. Durability of
antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol.
2007;10(6):817-26.
324. Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, et al. Vagus nerve stimulation
for depression: efficacy and safety in a European study. Psychol Med. 2008;38(5):651-61.
325. Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, et al. Two-year outcome
of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol.
2010;30(3):273-81.
326. Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, et al. A 1-year pilot
study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin
Psychiatry. 2008;69(2):183-9.
327. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12
months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol
Psychiatry. 2005;58(5):355-63.
328. Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for
refractory partial epilepsy. Epilepsy Behav. 2003;4(3):302-9.
329. Hallbook T, Lundgren J, Stjernqvist K, Blennow G, Stromblad LG, Rosen I. Vagus nerve
stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of
life, behaviour and mood. Seizure. 2005;14(7):504-13.
330. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A Pilot Study of Mood
in Epilepsy Patients Treated with Vagus Nerve Stimulation. Epilepsy Behav. 2000;1(2):93-9.
331. McGlone J, Valdivia I, Penner M, Williams J, Sadler RM, Clarke DB. Quality of life and memory
after vagus nerve stimulator implantation for epilepsy. Can J Neurol Sci. 2008;35(3):287-96.
332. Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, et al. Transcranial
magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002(2):CD003493.
333. Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation
in the treatment of depression: a review. J Clin Psychiatry. 2006;67(12):1870-6.
334. National Institute for Clinical Excellence (NICE). Intervencional procedures programme.
IPG242 Transcranial magnetic stimulation for severe depression London: NICE; 2007.
Disponible en: http://www.nice.org.uk/guidance/IPG242.
Guía de Práctica Clínica sobre el manejo de la depresión en el adulto 257